Quantification of fetal DNA by use of methylation-based DNA discrimination

Clinical Chemistry

Volumn 56, Issue 10, 2010, Pages 1627-1635

  Nygren, Anders O H ^a   Dean, Jarrod ^a   Jensen, Taylor J ^a   Kruse, Selena ^a   Kwong, William ^a   Van Den Boom, Dirk ^a   Ehrich, Mathias ^a  

^a SEQUENOM INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGONUCLEOTIDE; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR 3; UNCLASSIFIED DRUG; RESTRICTION ENDONUCLEASE; SOX14 PROTEIN, HUMAN; TBX3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; HUMAN; MATERNAL PLASMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; BLOOD; DNA MICROARRAY; FEASIBILITY STUDY; FETUS; GENETIC MARKER; GENETICS; HUMAN GENOME; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

DNA; DNA METHYLATION; DNA RESTRICTION ENZYMES; FEASIBILITY STUDIES; FEMALE; FETUS; GENETIC MARKERS; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SOXB2 TRANSCRIPTION FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-BOX DOMAIN PROTEINS;

EID: 77957736539     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.146290     Document Type: Article

References (32)

1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7. (Pubitemid 27343304)
2. Egan JF, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000;96:979-85.
3. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001;21:1070-4. (Pubitemid 34056191)
4. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, Ohama K. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002;110:75-9. (Pubitemid 36067421)
5. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998;352:1196.
6. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann NY Acad Sci 2004;1022:119-23. (Pubitemid 38951591)
7. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356:1170.
8. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843-9. (Pubitemid 40250368)
9. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8. (Pubitemid 29079115)
10. Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000;78(Suppl 2):155-62.
11. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007;39:197-207.
12. Horinek A, Korabecna M, Panczak A, Ulcova Gallova Z, Nouzova K, Calda P, Hancarova M. Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics. Fetal Diagn Ther 2008;24:15-21. (Pubitemid 352009138)
13. Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 2000;106:45-9. (Pubitemid 30156393)
14. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002;48:35-41.
15. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-8. (Pubitemid 44924994)
16. Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, et al. Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 2008;14:547-54.
17. Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 2009;29:1020-30.
18. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009;174:1609-18.
19. Old RW, Crea F, Puszyk W, Hulten MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007;15:227-35. (Pubitemid 47263333)
20. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 2005;102:14753-8.
21. Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008;54:500-11. (Pubitemid 351348156)
22. Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006;66:6118-28.
23. Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C, van den Boom D. Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci U S A 2008;105:4844. (Pubitemid 351753834)
24. Bird AP. Use of restriction enzymes to study eukaryotic DNA methylation, II: the symmetry of methylated sites supports semi-conservative copying of the methylation pattern. J Mol Biol 1978;118:49-60. (Pubitemid 8271372)
25. Ding C, Cantor CR. A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. Proc Natl Acad Sci U S A 2003;100:3059-64. (Pubitemid 36356539)
26. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, et al. Origins and functional impact of copy number variation in the human genome. Nature 2010;464:704-12.
27. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54:1664-72.
28. Zimmermann B, Zhong XY, Holzgreve W, Hahn S. Real-time quantitative polymerase chain reaction measurement of male fetal DNA in maternal plasma. Methods Mol Med 2007;132:43-9.
29. Stanghellini I, Bertorelli R, Capone L, Mazza V, Neri C, Percesepe A, Forabosco A. Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe. Mol Hum Reprod 2006;12:587-91. (Pubitemid 44642444)
30. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
31. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598-604. (Pubitemid 41233093)
32. Lo YM, Chiu RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem 2008;54:461-6.